SRDX - SurModics - Biotech IPO Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SRDX - SurModics - Biotech IPO

SRDX 31.15

+5.7%

Apr 28 3:59 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Lance Bredvold who wrote (65)	6/18/2023 5:48:21 PM
From: Lance Bredvold	of 83

And another 22% moderating to about 15% on June 6 or so. Can be attributed to the approval announcement for some POUNCE thrombus removal stents, both arterial and venous plus a positive review by Needham. We still await approval of the SurVeil drug coated balloon ( Wow! 250 cm .14mm and through the wrist to feet) stents but the sales people have several products to sell now. I'm a little disappointed in the rapidity of sales increases though management talks like they think them a great success. If/when the SurVeil approvals come through I expect the stock to jump back to the $40 range and then probably moderate a bit as sales and profits don't take off as fast as we speculators hoped.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next